Relapse-free survival (RFS) was comparable between both groups; however, stratification by number of AZA cycles administered showed a trend toward improved RFS in patients receiving more AZA therapy cycles ( 74 ).
← all excerpts
Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
1
—
—